Audited Supplier
50ml~1000ml
Internal Medicine
Injection
Elderly, Adult
Liquid
Injection
Inorganic Chemicals
Chemical Synthesis
20023252
SHIMEN
Plastic Bottle
50ml~1000ml
Hebei
3004909099
Product Description
Sodium Chloride Injection 0.9%
Product Name: Sodium Chloride InjectionMain ingredients and chemical name: Sodium Chloride
Structural formula: NaCl
Molecular formula : NaCl
Molecular weight: 58.44
Character The product is a colorless clear liquid, with salt flavor.
Pharmacology and toxicity
Sodium chloride is an electrolysis supplement agent; sodium and chloride are important electrolysis for the human body and mainly exist in extracellular fluid, which play an important role in maintaining normal volume of blood and extracellular fluid and osmosis pressure. Normal serum sodium concentration is about 135~145mmol/L, with a 92 percent of the plasma cation and a 90 percent of total osmosis pressure, so the quantity of plasma sodium play a decisive role for the osmosis pressure; normal serum chloride concentration is about 98~106mmol/L; sodium and chloride in human body are mainly adjusted by hypothalamus, lobus posterior hypophyseos and kindney so as to maintain the stability of body fluid volume and osmosis pressure.
Indications
It is indicated for dehydration caused by all kinds of cases, including hypoosmolality, isotonia and hypertonicity; also for the coma caused by hypertonicity non-ketosis diabetes as the administration of isotonia and hypoosmolality sodium chloride can correct the dehydration and hyperosmotic state;it is also indicated for low-chloride metabolic alkali poisoning; and external use sodium chloride can be used to wash the eyes and wounds; it also can be used for the induction of labor with water bag.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.
The products have been sold to some countries and regions in South America, Africa, and Asia.
